← FDA Drug Approvals (Drugs@FDA)

DOXYCYCLINE HYCLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2023-04-12

Drug application

FDA Application #
ANDA215583
Application type
Abbreviated New Drug Application (Generic)
Brand name
DOXYCYCLINE HYCLATE
Generic name
DOXYCYCLINE
Active ingredients
DOXYCYCLINE HYCLATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
GLAND
Manufacturer
JVET PHARMACEUTICALS LLC
First approval
2023-04-12

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown